FIELD: medicine.
SUBSTANCE: invention relates to ophthalmology and is intended for treating proliferative vitreoretinopathy in an experiment using liposome-associated melphalan. The medicinal product melphalan 0.0025 mg is administered once intravitreally in a volume of 0.1 ml. Melphalan is therein used as a lipophilic prodrug, diglyceride ester conjugate in the composition of a stealth liposomal form - pegylated form with a modified nanoparticle size of 500 nm.
EFFECT: method minimises the retinotoxic effect of melphalan.
1 cl, 2 ex, 2 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD FOR THE TREATMENT OF PROLIFERATIVE PROCESSES OF THE POSTERIOR SEGMENT OF THE EYE | 2018 | 
 | RU2684927C1 | 
| METHOD FOR SIMULATING PROLIFERATIVE VITREORETINOPATHY | 2014 | 
 | RU2568368C1 | 
| METHOD FOR SIMULATING PROLIFERATIVE VITREORETINOPATHY IN RATS | 2014 | 
 | RU2563368C1 | 
| METHOD FOR MODELING PROLIFERATIVE VITRORETINOPATHY | 1998 | 
 | RU2161335C2 | 
| METHOD FOR TREATING PROLIFERATIVE VITREORETINOPATHY | 2005 | 
 | RU2284812C1 | 
| METHOD OF EARLY DIAGNOSIS OF FAMILIAL EXUDATIVE RETINOPATHY IN CHILDREN | 2022 | 
 | RU2796894C1 | 
| METHOD FOR SIMULATING PROLIFERATIVE RETINOPATHY IN RATS | 2014 | 
 | RU2558991C1 | 
| SURGICAL METHOD FOR TREATING THE CASES OF REGMATOGENIC RETINAL DETACHMENT COMBINED WITH POSTERIOR DETACHMENT OF VITREOUS BODY | 2000 | 
 | RU2203001C2 | 
| METHOD FOR PREVENTING PROLIFERATIVE VITREORETINOPATHY | 1999 | 
 | RU2175223C2 | 
| SURGICAL METHOD FOR TREATING THE CASES OF AMOTIO RETINAE RECURRENCE IN PERFORMING VITREAL CAVITY TAMPONADE WITH SILICON OIL | 2001 | 
 | RU2190377C1 | 
Authors
Dates
2022-05-23—Published
2021-07-05—Filed